|国家科技期刊平台
首页|期刊导航|中国医学创新|经鼻高流量湿化氧疗在重症肺部感染合并呼吸衰竭患者脱机后的应用

经鼻高流量湿化氧疗在重症肺部感染合并呼吸衰竭患者脱机后的应用OA

Application of High-flow Nasal Canula in Patients with Severe Pulmonary Infection Complicated with Respiratory Failure after Weaning

中文摘要英文摘要

目的:探究经鼻高流量湿化氧疗(HFNC)在重症肺部感染合并呼吸衰竭患者脱机后的应用.方法:拟选取 2022 年 9 月—2023 年 5 月广东省人民医院赣州医院(赣州市立医院)收治的重症肺部感染合并呼吸衰竭患者 90 例为研究对象,经随机数字表法,分为对照组与观察组,各 45 例.所有患者均满足脱机标准,对照组脱机后予以常规氧疗,观察组脱机后给予HFNC.比较两组脱机成功率及成功脱机24、48、96 h及1周后的再插管率,以及血清中Th1、Th2细胞因子[肿瘤坏死因子-α(TNF-α)和白细胞介素(IL)-6]水平,观察脱机后 12、24 h的血气分析[动脉血氧分压(PaO2)、动脉血二氧化碳分压(PaCO2)、动脉血氧饱和度(SaO2)],并统计两组氧疗 24 h内低血氧症发生率和氧疗 1 周内并发症发生情况.结果:观察组脱机后 12、24 h的PaO2、SaO2 均高于对照组,脱机后 24 h的PaCO2 低于对照组(P<0.05).两组脱机成功率比较,差异无统计学意义(P>0.05).两组成功脱机 24 h后再插管率比较,差异无统计学意义(P>0.05);观察组成功脱机 48、96 h及 1 周后的再插管率均显著低于对照组(P<0.05).观察组氧疗 24 h内低血氧症发生率和氧疗 1 周内其他并发症发生率均低于对照组(P<0.05).治疗后,两组TNF-α、IL-6 水平均下降,且观察组均低于对照组(P<0.05).结论:HFNC可有效改善重症肺部感染合并呼吸衰竭患者脱机后的血气指标,有效调节Th1、Th2 细胞因子,减轻肺部炎症,改善呼吸功能,提高脱机成功率,降低并发症发生率及再插管率.

Objective:To investigate the application of high-flow nasal canula(HFNC)in patients with severe pulmonary infection complicated with respiratory failure after weaning.Method:A total of 90 patients with severe pulmonary infection complicated with respiratory failure admitted to Ganzhou Hospital of Guangdong Provincial People's Hospital(Ganzhou Municipal Hospital)from September 2022 to May 2023 were selected as the study objects,and they were divided into control group and observation group by random number table method,with 45 cases in each group.All patients met the weaning criteria.The control group was given conventional oxygen therapy after weaning,and the observation group was given HFNC after weaning.The success rate of weaning and the rate of re-intubation after successful weaning 24,48,96 h and 1 week and the levels of Th1 and Th2 cytokines[tumor necrosis factor-α(TNF-α)and interleukin(IL)-6]in serum were compared between the two groups.Blood gas analysis[arterial partial pressure of oxygen(PaO2),arterial partial pressure of carbon dioxide(PaCO2),arterial oxygen saturation(SaO2)]of the two groups at 12 and 24 h after weaning were observed,and the incidence of hypoxemia within 24 h of oxygen therapy and complications within 1 week of oxygen therapy in the two groups were analyzed.Result:PaO2 and SaO2 levels in observation group were higher than those in control group at 12 and 24 h after weaning,and PaCO2 level at 24 h after weaning was lower than that in control group(P<0.05).There was no significant difference in weaning success rate between the two groups(P>0.05).There was no significant difference in the rate of re-intubation between the two groups after 24 h successful weaning(P>0.05).The re-intubation rates of the observation group 48,96 h and 1 week after successful weaning were significantly lower than those of the control group(P<0.05).The incidences of hypoxemia within 24 h oxygen therapy and other complications within 1 week of oxygen therapy in observation group were lower than those in control group(P<0.05).After treatment,the levels of TNF-α and IL-6 were decreased in both groups,and those in the observation group were lower than those in the control group(P<0.05).Conclusion:HFNC can effectively improve blood gas indexes in patients with severe pulmonary infection complicated with respiratory failure after weaning,effectively regulate Th1,Th2 cytokines,reduce pulmonary inflammation,improve respiratory function,increase the success rate of weaning,and reduce the incidence of complications and re-intubation rate.

康欢;曾期龙;刘伟

广东省人民医院赣州医院(赣州市立医院)重症医学科 江西 赣州 341000

高流量湿化氧疗重症肺部感染呼吸衰竭细胞因子

High-flow nasal cannulaSevere pulmonary infectionRespiratory failureCytokine

《中国医学创新》 2024 (018)

18-22 / 5

赣州市指导性科技计划项目(20222ZDX9574)

10.3969/j.issn.1674-4985.2024.18.005

评论